Yu T. Wang
Hebei Key Laboratory Of Forensic Medicine
Shijiazhuang, 050017, China
Shijiazhuang, 050017, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Endogenous and Exogenous Small RNA Signatures as Novel Tools for Postmortem Interval Determination.
Journal: Biomolecules
Published: February 05, 2026
Prenatal exposure to low-dose ciprofloxacin antibiotic increased male offspring's defensive aggressive behaviors via a gut-phosphatidylcholine-α7 nAChR axis.
Journal: Brain, behavior, and immunity
Published: December 18, 2025
Mental health of rural doctors and influencing factors in Hebei, China.
Journal: Primary health care research & development
Published: July 11, 2025
Retraction: miR-15b represses BACE1 expression in sporadic Alzheimer's disease.
Journal: Oncotarget
Published: January 20, 2025
Repetitive Transcranial Magnetic Stimulation Induces Cognitive Recovery in Alzheimer's Disease via GABAergic Neuron Activation of the Cx3cl1-Cx3cr1 Axis.
Journal: Cell proliferation
Published: December 23, 2024
Repetitive Transcranial Magnetic Stimulation-Mediated Neuroprotection in the 5xFAD Mouse Model of Alzheimer's Disease Through GABRG2 and SNAP25 Modulation.
Journal: Molecular neurobiology
Published: March 11, 2024
Testosterone deficiency worsens mitochondrial dysfunction in APP/PS1 mice.
Journal: Frontiers in aging neuroscience
Published: February 24, 2024
Edaravone Dexborneol ameliorates the cognitive deficits of APP/PS1 mice by inhibiting TLR4/MAPK signaling pathway via upregulating TREM2.
Journal: Neuropharmacology
Published: January 30, 2024
Correction to: D-beta-hydroxybutyrate protects against microglial activation in lipopolysaccharide-treated mice and BV-2 cells.
Journal: Metabolic brain disease
Published: January 04, 2023
D-beta-hydroxybutyrate protects against microglial activation in lipopolysaccharide-treated mice and BV-2 cells.
Journal: Metabolic brain disease
Published: July 22, 2022
Last Updated: 09/26/2026